On Sunday, the Israeli ministry announced that on Nov. 1, after obtaining regulatory approval, Israel will begin clinical trials for a possible COVID-19 vaccine.
Previously In March, the Israel Institute for Biological Research began testing the “BriLife” vaccine on animals.
During the new stage of tests, eight volunteers between the ages of 15 and 55 will be given the vaccine and have their progress monitored to see if their bodies produce any virus antibodies.
In December, the second stage of trials for the vaccine is expected to take place, in which 960 volunteers aged 18 and over will be given the vaccine.
If the November and December trials succeed, in the April/May time, a group of 30,000 volunteers will be given the vaccine so that scientists can validate its effectiveness and safety.
Lastly, if the April/May vaccine trials succeed, the COVID-19 vaccine will then be available to the general public.
In total, Israel has reported 309,413 COVID-19 cases and 2,372 coronavirus related fatalities.
The United States is currently leading global COVID-19 cases with over 8.8 million infections and 230,235 fatalities, although India follows closely behind with 7.9 million cases and 119,030 deaths. As for the third-highest case toll and death toll, Brazil follows with 5.3 million cases and 156,952 deaths, Russia with 1.5 million cases and 156,952 deaths, and Spain with 1.1 million infections and 34,752 deaths.
The novel coronavirus was first discovered in Wuhan, Hubei, China, on Dec. 31, 2019, and has infected more than 42 million individuals worldwide, resulting in over 1.3 million fatalities across 188 countries and territories.
The Panthera Post 